Company Overview
- Formerly known as Libra Capital Advisors HK Limited., we have invested in Hospitals and Rehabilitation Centers in Hong Kong, Taiwan and China. Since the breakout of the Covid-19 Epidemic in January 2020, we were invited by Our Strategic Partner, AleDiagnostics Inc. of USA, and major POCT Manufacturers in China to jointly develop and manufacture a Full Range of COVID-19 Diagnostic Detection Test Kits. Including Patented RT-PCR Nucleic Acid 20-minutes Rapid Test for COVID-19 + Flu A/B Virus. Patented Microfluidic Biosensors 4-minutes Rapid Test for COVID-19 IgM/IgG + SAA/CRP Combo Test and Colloidal Gold 15-minutes Rapid Test for COVID Antigen, Antigen Flu A/B Combo and COVID Antibodies Test.
Based on the exnt performance of our roducts, in terms of Sensitivity, Specificity, Accuracy and Speed, we have developed a spectrum of our Product Application Programs (PAP) as solutions to tackle different Commercial and Social Problems created by the COVID-19 Pandemic.We aim to provide a HOLISTIC SYSTEM, a suite of SOLUTIONS that addresses the Pandemic’s need to identify the infection.
COVID-19 ANTIGEN RAPID TEST
Pathological Analysis Equipments
COVID-19 + FLU A/B ANTIGEN COMBO RAPID TEST
Pathological Analysis Equipments
COVID-19 IgM/IgG RAPID TEST
Pathological Analysis Equipments
COVID-19 RT-PCR DIAGNOSTIC TEST
Pathological Analysis Equipments
COVID-19 + FLU A/B RT-PCR COMBO DIAGNOSTIC TEST
Pathological Analysis Equipments
